> American’s subsidize big pharma
I think that’s true. But Americans are also voting with our credit cards when we (I think?) order only a small fraction of pharms from overseas vendors.
I don’t see how we can have it both ways: enforceable patents, and low prices in new drugs.
The public face of the drug companies is beyond irritating, with TV ads that spend 80% of the time on stupid disclaimers.
I’d like to understand better of how our regulatory environment developed. Do our very long processes actually reduce the number of bad products or are they in place to be a barrier-to-entry for competition?
I’ve seen both.